|
1
|
A phosphorus-based dendrimer targets inflammation and osteoclastogenesis in experimental arthritis.
|
Sci Transl Med
|
2011
|
1.69
|
|
2
|
Human gamma delta T cells induce dendritic cell maturation.
|
Clin Immunol
|
2002
|
1.29
|
|
3
|
FcgammaRIII discriminates between 2 subsets of Vgamma9Vdelta2 effector cells with different responses and activation pathways.
|
Blood
|
2004
|
1.27
|
|
4
|
Targeting monocytes/macrophages in the treatment of rheumatoid arthritis.
|
Rheumatology (Oxford)
|
2012
|
1.23
|
|
5
|
A regulatory cross-talk between Vgamma9Vdelta2 T lymphocytes and mesenchymal stem cells.
|
Eur J Immunol
|
2009
|
1.02
|
|
6
|
PGE2 inhibits natural killer and gamma delta T cell cytotoxicity triggered by NKR and TCR through a cAMP-mediated PKA type I-dependent signaling.
|
Biochem Pharmacol
|
2010
|
1.01
|
|
7
|
The gene expression profile of phosphoantigen-specific human γδ T lymphocytes is a blend of αβ T-cell and NK-cell signatures.
|
Eur J Immunol
|
2011
|
0.99
|
|
8
|
Hospicells derived from ovarian cancer stroma inhibit T-cell immune responses.
|
Int J Cancer
|
2010
|
0.91
|
|
9
|
Multiplication of human natural killer cells by nanosized phosphonate-capped dendrimers.
|
Angew Chem Int Ed Engl
|
2007
|
0.88
|
|
10
|
Anti-inflammatory and immunosuppressive activation of human monocytes by a bioactive dendrimer.
|
J Leukoc Biol
|
2008
|
0.86
|
|
11
|
Pitfalls on the roadmap to gammadelta T cell-based cancer immunotherapies.
|
Immunol Lett
|
2009
|
0.85
|
|
12
|
Tailored control and optimisation of the number of phosphonic acid termini on phosphorus-containing dendrimers for the ex-vivo activation of human monocytes.
|
Chemistry
|
2008
|
0.85
|
|
13
|
Lenalidomide down regulates the production of interferon-gamma and the expression of inhibitory cytotoxic receptors of human Natural Killer cells.
|
Cell Immunol
|
2010
|
0.84
|
|
14
|
Design of phosphorylated dendritic architectures to promote human monocyte activation.
|
FASEB J
|
2006
|
0.84
|
|
15
|
Pre-eminence and persistence of immature natural killer cells in acute myeloid leukemia patients in first complete remission.
|
Am J Hematol
|
2010
|
0.82
|
|
16
|
Trogocytosis and killing of IL-4-polarized monocytes by autologous NK cells.
|
J Leukoc Biol
|
2008
|
0.81
|
|
17
|
Anti-inflammatory properties of dendrimers per se.
|
ScientificWorldJournal
|
2011
|
0.81
|
|
18
|
Dendrimers ended by non-symmetrical azadiphosphonate groups: synthesis and immunological properties.
|
Bioorg Med Chem Lett
|
2009
|
0.80
|
|
19
|
An azabisphosphonate-capped poly(phosphorhydrazone) dendrimer for the treatment of endotoxin-induced uveitis.
|
Molecules
|
2013
|
0.79
|
|
20
|
Modulation of pro-inflammatory activation of monocytes and dendritic cells by aza-bis-phosphonate dendrimer as an experimental therapeutic agent.
|
Arthritis Res Ther
|
2014
|
0.78
|
|
21
|
Phosphorus-Based Dendrimer ABP Treats Neuroinflammation by Promoting IL-10-Producing CD4(+) T Cells.
|
Biomacromolecules
|
2015
|
0.78
|
|
22
|
Repeated intravenous injections in non-human primates demonstrate preclinical safety of an anti-inflammatory phosphorus-based dendrimer.
|
Nanotoxicology
|
2014
|
0.77
|